Search Results

Inari Medical Appoints Dr. Victor F. Tapson as VP of Medical Affairs

September 21, 2021—Inari Medical, Inc. a medical device company focused on the treatment of venous diseases, announced that the company has appointed Victor F. Tapson, MD, as Vice President of Medical Affairs.

Results Published From OPTALYSE PE Trial of BTG's Ekos System

July 23, 2018—BTG International announced the publication of the OPTALYSE PE trial results by Victor F. Tapson, MD, et al in Journal of the American College of Cardiology: Cardiovascular Interventions (2018:11;1401–1410). The findings were presented at the Society for Cardiovascular Angiography and Interventions scientific sessions, held April 25–28 in San Diego, California.

Results Published for Bio2 Medical's Angel Catheter Pivotal Study

June 29, 2017—Bio2 Medical announced that the results of the pivotal study for the company's Angel catheter were published by Victor F. Tapson, MD, et al online ahead of print in Journal of Vascular and Interventional Radiology (JVIR). The study met all safety endpoints and showed that the Angel catheter demonstrated a significant reduction in clinically significant and fatal pulmonary embolism (PE). The data will be presented at the 76th annual meeting of the American Association for the Surgery of Trauma and Clinical Congress of Acute Care Surgery on September 13–16 in Baltimore, Maryland.

Penumbra's Indigo Aspiration System Meets Primary Endpoints in EXTRACT-PE Trial

November 6, 2019—Penumbra, Inc. announced that the EXTRACT-PE trial met its primary endpoints, demonstrating the safety and efficacy of the company’s Indigo aspiration system for aspiration mechanical thrombectomy in patients with acute pulmonary embolism (PE).